Patents by Inventor Garrick Wallstrom

Garrick Wallstrom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230243829
    Abstract: The present invention provides reagents and methods for breast cancer detection.
    Type: Application
    Filed: February 24, 2023
    Publication date: August 3, 2023
    Inventors: Joshua LABAER, Karen Sue ANDERSON, Garrick WALLSTROM, Sahar SIBANI, Niroshan RAMACHANDRAN
  • Patent number: 11624747
    Abstract: The present invention provides reagents and methods for breast cancer detection.
    Type: Grant
    Filed: September 9, 2020
    Date of Patent: April 11, 2023
    Assignees: ARIZONA BOARD OF REGENTS, DANA-FARBER CANCER INSTITUTE, INC., President and Fellows of Harvard College
    Inventors: Joshua Labaer, Karen Sue Anderson, Garrick Wallstrom, Sahar Sibani, Niroshan Ramachandran
  • Publication number: 20230079737
    Abstract: Cancer patients make antibodies to tumor-derived proteins that are potential biomarkers for early detection. Twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer (Tables 1, 2). Also, a 13-AAb classifier has been developed that differentiate patients with BLBC from healthy controls with 33% sensitivity at 98% specificity (Table 3).
    Type: Application
    Filed: September 8, 2022
    Publication date: March 16, 2023
    Inventors: Joshua LaBaer, Jie Wang, Ji Qiu, Garrick Wallstrom, Karen Anderson, Jin Park, Jonine Figueroa
  • Patent number: 11525831
    Abstract: Cancer patients make antibodies to tumor-derived proteins that are potential biomarkers for early detection. Twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer (Tables 1, 2). Also, a 13-AAb classifier has been developed that differentiate patients with BLBC from healthy controls with 33% sensitivity at 98% specificity (Table 3).
    Type: Grant
    Filed: January 15, 2020
    Date of Patent: December 13, 2022
    Assignees: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY, THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Joshua LaBaer, Jie Wang, Ji Qui, Garrick Wallstrom, Karen Anderson, Jin Park, Jonine Figueroa
  • Publication number: 20220163531
    Abstract: Compositions and methods relating to a panel of antigen biomarkers for the early detection of ovarian cancer. The compositions and methods encompass antigen biomarkers coupled to a substrate, with the biomarkers being selected from the group consisting of one or more of ICAM3, CTAG2, p53, STYXL1, PVR, POMC, NUDT11, TRIM39, UHMK1, KSR1, and NXF3.
    Type: Application
    Filed: December 28, 2021
    Publication date: May 26, 2022
    Inventors: Benjamin Katchman, Karen Anderson, Garrick Wallstrom, Joshua LaBaer, Daniel Cramer
  • Patent number: 11243208
    Abstract: Compositions and methods relating to a panel of antigen biomarkers for the early detection of ovarian cancer. The compositions and methods encompass antigen biomarkers coupled to a substrate, with the biomarkers being selected from the group consisting of one or more of ICAM3, CTAG2, p53, STYXL1, PVR, POMC, NUDT11, TRIM39, UHMK1, KSR1, and NXF3.
    Type: Grant
    Filed: July 11, 2017
    Date of Patent: February 8, 2022
    Assignees: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY, THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Benjamin Katchman, Karen Anderson, Garrick Wallstrom, Joshua LaBaer, Daniel Cramer
  • Publication number: 20200407792
    Abstract: Disclosed herein are compositions and methods for accurately estimating the absorbed dose of radiation indicated by a subject based on the expression pattern of a panel of radiation-modulated (RM) genes at various time points following exposure of the subject to ionizing radiation.
    Type: Application
    Filed: July 15, 2020
    Publication date: December 31, 2020
    Inventors: Joshua LaBaer, Kristin Gillis, Garrick Wallstrom, Jin Park, Vel Murugan, Mitch Magee
  • Publication number: 20200400671
    Abstract: The present invention provides reagents and methods for breast cancer detection.
    Type: Application
    Filed: September 9, 2020
    Publication date: December 24, 2020
    Inventors: Joshua LABAER, Karen Sue ANDERSON, Garrick WALLSTROM, Sahar SIBANI, Niroshan RAMACHANDRAN
  • Patent number: 10802026
    Abstract: The present invention provides reagents and methods for breast cancer detection.
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: October 13, 2020
    Assignees: Arizona Board of Regents, a Body Corporate acting for and on behalf of Arizona State University, Dana-Farber Cancer Institute, Inc., President and Fellows of Harvard College
    Inventors: Joshua Labaer, Karen Sue Anderson, Garrick Wallstrom, Sahar Sibani, Niroshan Ramachandran
  • Patent number: 10787710
    Abstract: Disclosed herein are compositions and methods for accurately estimating the absorbed dose of radiation indicated by a subject based on the expression pattern of a panel of radiation-modulated (RM) genes at various time points following exposure of the subject to ionizing radiation.
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: September 29, 2020
    Assignee: Arizona Board of Regents on behalf of Arizona State University
    Inventors: Joshua LaBaer, Kristin Gillis, Garrick Wallstrom, Jin Park, Vel Murugan, Mitch Magee
  • Publication number: 20200182874
    Abstract: Cancer patients make antibodies to tumor-derived proteins that are potential biomarkers for early detection. Twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer (Tables 1, 2). Also, a 13-AAb classifier has been developed that differentiate patients with BLBC from healthy controls with 33% sensitivity at 98% specificity (Table 3).
    Type: Application
    Filed: January 15, 2020
    Publication date: June 11, 2020
    Inventors: Joshua LaBaer, Jie Wang, Ji Qui, Garrick Wallstrom, Karen Anderson, Jin Park, Jonine Figueroa
  • Publication number: 20200010899
    Abstract: Disclosed herein are compositions and methods for accurately estimating the absorbed dose of radiation indicated by a subject based on the expression pattern of a panel of radiation-modulated (RM) genes at various time points following exposure of the subject to ionizing radiation.
    Type: Application
    Filed: August 5, 2019
    Publication date: January 9, 2020
    Inventors: Joshua LaBaer, Kristin Gillis, Garrick Wallstrom, Jin Park, Vel Murugan, Mitch Magee
  • Patent number: 10435747
    Abstract: Disclosed herein are compositions and methods for accurately estimating the absorbed dose of radiation indicated by a subject based on the expression pattern of a panel of radiation-modulated (RM) genes at various time points following exposure of the subject to ionizing radiation.
    Type: Grant
    Filed: August 11, 2015
    Date of Patent: October 8, 2019
    Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
    Inventors: Joshua LaBaer, Kristin Gillis, Garrick Wallstrom, Jin Park, Vel Murugan, Mitch Magee
  • Publication number: 20190302122
    Abstract: Compositions and methods relating to a panel of antigen biomarkers for the early detection of ovarian cancer. The compositions and methods encompass antigen biomarkers coupled to a substrate, with the biomarkers being selected from the group consisting of one or more of ICAM3, CTAG2, p53, STYXL1, PVR, POMC, NUDT11, TRIM39, UHMK1, KSR1, and NXF3.
    Type: Application
    Filed: July 11, 2017
    Publication date: October 3, 2019
    Inventors: Benjamin Katchman, Karen Anderson, Garrick Wallstrom, Joshua LaBaer, Daniel Cramer
  • Publication number: 20190162725
    Abstract: Embodiments of the present disclosure relate generally to detection and diagnosis of tuberculosis (TB) infections. More particularly, the present disclosure provides novel immunogenic biomarkers associated with TB infections for the diagnosis and treatment of TB. Novel TB biomarkers can enhance the diagnosis and treatment of TB by providing greater accuracy and efficiency, especially for point-of-care technologies.
    Type: Application
    Filed: November 29, 2018
    Publication date: May 30, 2019
    Inventors: Mitch Magee, Joshua LaBaer, Lusheng Song, Garrick Wallstrom, Jacqueline Achkar
  • Publication number: 20190004051
    Abstract: An immune-proteomic screening of AAb responses using protein arrays has identified two panels of Aab (antigen/antibody complexes) that can potentially differentiate lung adenocarcinoma from smoker controls as well as CT positive benign lung disease. The resulting biomarkers appear to have high specificity so that high risk subjects with a positive CT screen and a positive serum test should get more invasive test such as needle biopsy for a timely cancer diagnosis, among other advantages.
    Type: Application
    Filed: January 11, 2017
    Publication date: January 3, 2019
    Inventors: Joshua Labaer, Ji Qiu, Jie Wang, Garrick Wallstrom, Jin Park, William Rom, Harvey Pass
  • Publication number: 20180067117
    Abstract: The present invention provides reagents and methods for breast cancer detection.
    Type: Application
    Filed: November 21, 2017
    Publication date: March 8, 2018
    Inventors: Joshua LABAER, Karen Sue ANDERSON, Garrick WALLSTROM, Sahar SIBANI, Niroshan RAMACHANDRAN
  • Patent number: 9857374
    Abstract: The present invention provides reagents and methods for breast cancer detection.
    Type: Grant
    Filed: August 15, 2011
    Date of Patent: January 2, 2018
    Assignees: Arizona Board of Regents, A Body Corporate Acting For and On Behalf of Arizona State University, President and Fellows of Harvard College, Dana Farber Cancer Institute, Inc.
    Inventors: Joshua LaBaer, Karen Sue Anderson, Garrick Wallstrom, Sahar Sibani, Niroshan Ramachandran
  • Publication number: 20170363631
    Abstract: Cancer patients make antibodies to tumor-derived proteins that are potential biomarkers for early detection. Twenty-eight antigens have been identified as potential biomarkers for the early detection of basal-like breast cancer (Tables 1, 2). Also, a 13-AAb classifier has been developed that differentiate patients with BLBC from healthy controls with 33% sensitivity at 98% specificity (Table 3).
    Type: Application
    Filed: December 9, 2015
    Publication date: December 21, 2017
    Inventors: Joshua LaBaer, Jie Wang, Ji Qiu, Garrick Wallstrom, Karen Anderson, Jin Park, Jonine Figueroa
  • Publication number: 20160083793
    Abstract: Disclosed herein are compositions and methods for accurately estimating the absorbed dose of radiation indicated by a subject based on the expression pattern of a panel of radiation-modulated (RM) genes at various time points following exposure of the subject to ionizing radiation.
    Type: Application
    Filed: August 11, 2015
    Publication date: March 24, 2016
    Inventors: Joshua LaBaer, Kristin Gillis, Garrick Wallstrom, Jin Park, Vel Murugan, Mitch Magee